BLUEROCK THERAPEUTICS
BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.
BLUEROCK THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.bluerocktx.com
Total Employee:
101+
Status:
Active
Total Funding:
225 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Regenative Labs
Regenative Labs is a biotechnology research firm that produces regenerative medicine products.
Rion
RION is a clinical-stage regenerative medicine company.
SanBio
SanBio is a regenerative medicine company.
Saphetor
Saphetor is a personalised medicine company.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Current Advisors List
Board_member
2021-07-01
Current Employees Featured
Stefan Irion SVP Research @ BlueRock Therapeutics
SVP Research
2021-02-01
Ibrahim Domian Senior Medical Director @ BlueRock Therapeutics
Senior Medical Director
2019-07-01
Robert Deans Chief Technology Officer @ BlueRock Therapeutics
Chief Technology Officer
2017-01-01
Seth Ettenberg President and CEO @ BlueRock Therapeutics
President and CEO
2021-07-01
Stefan Irion VP, Translational Neuroscience @ BlueRock Therapeutics
VP, Translational Neuroscience
2019-01-01
Gordon Keller Scientific Founder, Director @ BlueRock Therapeutics
Scientific Founder, Director
Michael Scott Senior Vice President, Product Development @ BlueRock Therapeutics
Senior Vice President, Product Development
2017-06-01
Stefan Irion Senior Director CNS @ BlueRock Therapeutics
Senior Director CNS
2017-08-01
Eric Soller Vice President, Corporate Development & Strategy @ BlueRock Therapeutics
Vice President, Corporate Development & Strategy
2016-12-01
Ryan Bloom Director, Business Development and New Product Planning @ BlueRock Therapeutics
Director, Business Development and New Product Planning
2020-03-01
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series A - BlueRock Therapeutics
Bayer
Bayer investment in Series A - BlueRock Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-26 | BlueRock Therapeutics Announces New Board Chair, New President and CEO |
| 2020-03-04 | BlueRock Hires Former Unum Exec Ettenberg as Chief Scientific Officer |
Official Site Inspections
http://www.bluerocktx.com Semrush global rank: 4.41 M Semrush visits lastest month: 2.53 K
- Host name: acd92bd2ba22672fa.awsglobalaccelerator.com
- IP address: 99.83.192.58
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "BlueRock Therapeutics"
About - BlueRock Therapeutics LP
Learn about BlueRock's mission, leadership, & insights. See the science of cell and gene therapy and how it's transforming disease treatment.See details»
Leadership - BlueRock Therapeutics LP
Stefan Irion, M.D., leads the Research organization at BlueRock Therapeutics. Since joining BlueRock in 2017, Stefan has taken on a number of roles in support of BlueRock’s scientific …See details»
BlueRock Therapeutics - Crunchbase Company Profile …
Contact Email opportunities@bluerocktx.com BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform.See details»
BlueRock Therapeutics - LinkedIn
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform …See details»
BlueRock Therapeutics Management Team | Org Chart
BlueRock Therapeutics employs 528 employees. The BlueRock Therapeutics management team includes Craig Beasley (Chief Technology Officer), Amit Rakhit (Chief Development and …See details»
BlueRock Therapeutics Overview | SignalHire Company Profile
BlueRock Therapeutics is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. …See details»
BlueRock Therapeutics Company Profile | Management and
SQL International Organization for Standardization . SAS Macro SAS . Python Python Software Foundation . CSS World Wide Web Consortium . PHP PHP . ... Smith@bluerocktx.com: …See details»
BlueRock Therapeutics - Company Profile & Staff Directory
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform …See details»
Bayer acquires BlueRock Therapeutics to build leading position in …
“We are extremely excited to be part of the world-class Bayer organization,” said Emile Nuwaysir, Ph.D., Chief Executive Officer, BlueRock Therapeutics. “We have built a premier cell therapy …See details»
BlueRock Therapeutics - Overview, News & Similar companies
May 22, 2024 BlueRock Therapeutics contact info: Phone number: (857) 299-7589 Website: www.bluerocktx.com What does BlueRock Therapeutics do? BlueRock Therapeutics, a wholly …See details»
Working at BlueRock Therapeutics - Zippia
Mar 14, 2024 bluerocktx.com. Organization Type. Private. CEO. Seth Ettenberg. Social Media. BlueRock Therapeutics is an engineered cell therapy company with a mission to develop …See details»
BlueRock Therapeutics (Canada) Funding: $225M - Medical Startups
Dec 10, 2024 BlueRock Therapeutics is pioneering cell therapies that replace dead, damaged, or dysfunctional cells to restore critical natural functions in the body. The company is initially …See details»
BlueRock Therapeutics Announces New Board Chair, New …
Since joining BlueRock in 2020, Dr. Ettenberg has been an exceptional leader of the Research organization, helping to shape the pipeline and advance BlueRock’s proprietary cell+gene …See details»
BlueRock Therapeutics: Employee Directory | ZoomInfo.com
May 26, 2024 BlueRock Therapeutics Contact Info: Phone number: (857) 299-7589 Website: www.bluerocktx.com What does BlueRock Therapeutics do? BlueRock Therapeutics, a wholly …See details»
Senior VP, Research at BlueRock Therapeutics - ZoomInfo
Senior VP, Research at BlueRock Therapeutics View Contact Info for Free . Stefan Irion Email & Phone number. Engage via Email. s***@bluerocktx.comSee details»
BlueRock Therapeutics | LinkedIn
BlueRock Therapeutics | 65,765 followers on LinkedIn. Striving to transform the treatment of disease by harnessing the power of cell therapy | BlueRock Therapeutics is a leading …See details»
Mission & Values - BlueRock Therapeutics LP
No matter our differences, we know that by living, supporting and championing our values, each one of us plays a critical role in our mission to change the way we treat disease and improve …See details»
Texas border town wins $13M grant for environment work - The …
1 hour ago Presidio, northwest of Big Bend National Park, will get dedicated green spaces along bike lanes and pedestrian streets, plant thousands of native trees and establish a high-school …See details»
Seth Ettenberg - President & Chief Executive Officer at ... - ZoomInfo
Seth Ettenberg contact details: Email address: s***@bluerocktx.com Phone number: (857) ***-**** Who is Seth Ettenberg? Seth Ettenberg, PhD, is the current President and CEO of BlueRock …See details»
BlueRock Therapeutics Appoints Seth Ettenberg, Ph.D. Chief …
Strengthens leadership team and adds deep expertise in engineered cell therapies; CAMBRIDGE, Mass., March 03, 2020 (GLOBE NEWSWIRE) — BlueRock Therapeutics, LP today …See details»